» Authors » Getu Diriba

Getu Diriba

Explore the profile of Getu Diriba including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 48
Citations 292
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Diriba G, Alemu A, Yenew B, Ayano B, Hailu M, Buta B, et al.
J Glob Antimicrob Resist . 2025 Feb; PMID: 39988072
Objectives: To estimate the proportion of second-line anti-tuberculosis drug resistance among multidrug-resistant tuberculosis (MDR-TB) patients in Ethiopia. Methodology: A laboratory-based prospective cross-sectional study was conducted at the National Tuberculosis Reference...
2.
Seid G, Alemu A, Diriba G, Hailu M, Wondimu A, Tadesse M, et al.
PLoS One . 2025 Feb; 20(2):e0316903. PMID: 39964990
Background: There was a 'missing millions' gap between the incidence of tuberculosis (TB) cases and the notified cases. In many TB high-burden countries, only about 25% of household contacts (HHCs)...
3.
Alemu A, Seid G, Diriba G, Hailu M, Dange B, Moga S, et al.
Arch Public Health . 2025 Feb; 83(1):40. PMID: 39953616
Background: Individuals with diabetes mellitus (DM) have high tuberculosis (TB) prevalence. Currently, the incidence of DM is increasing in low and middle-income countries including Ethiopia where TB is also endemic,...
4.
Alemu A, Diriba G, Seid G, Wondimu A, Moga S, Tadesse G, et al.
IJID Reg . 2025 Jan; 14:100551. PMID: 39877411
Objectives: To assess tuberculosis (TB) and associated factors among patients with presumptive TB with chronic kidney disease (CKD). Methods: A prospective cross-sectional study was conducted from January to December 2023...
5.
Mollalign H, Hailu Alemayehu D, Beyene D, Melaku K, Ayele A, Chala D, et al.
Res Sq . 2025 Jan; PMID: 39764135
Globally, drug-resistant tuberculosis (DR-TB) is responsible for 13% of mortality attributable to antimicrobial resistance. In Ethiopia, extrapulmonary tuberculosis (EPTB) is a significant public health challenge, and drug resistance (DR) in...
6.
Diriba G, Alemu A, Ayano B, Yenew B, Hailu M, Buta B, et al.
IDCases . 2024 May; 36:e01988. PMID: 38779144
Background: Bedaquiline (BDQ) is an effective drug currently used for multidrug-resistant or rifampicin-resistant TB (MDR/RR-TB) and pre-extensively drug-resistant TB (pre-XDR-TB) treatment. However, resistance to this new drug is emerging. We...
7.
Seid G, Alemu A, Diriba G, Zerihun B, Abebaw Y, Moga S, et al.
Heliyon . 2024 May; 10(10):e30942. PMID: 38770348
Introduction: There is a global gap between tuberculosis incident cases and the notified cases. Active household contact investigation is one of the strategies to narrow this gap. It has the...
8.
Yenew B, de Haas P, Babo Y, Diriba G, Sherefdin B, Bedru A, et al.
ERJ Open Res . 2024 May; 10(3). PMID: 38770005
Background: Childhood tuberculosis (TB) diagnosis remains challenging, partly because children cannot provide sputum. This study evaluated the diagnostic accuracy of the Simple One-Step (SOS) stool method with Xpert MTB/RIF Ultra...
9.
Yenew B, Kebede A, Alemu A, Diriba G, Mehammed Z, Amare M, et al.
PLoS One . 2024 May; 19(5):e0303460. PMID: 38753615
Background: The emergence of drug-resistant tuberculosis (DR-TB) has been a major obstacle to global tuberculosis control programs, especially in developing countries, including Ethiopia. This study investigated drug resistance patterns and...
10.
Getahun M, Beyene D, Mollalign H, Diriba G, Tesfaye E, Yenew B, et al.
Sci Rep . 2024 May; 14(1):10455. PMID: 38714745
Ethiopia is one of the countries with a high tuberculosis (TB) burden, yet little is known about the spatial distribution of Mycobacterium tuberculosis (Mtb) lineages. This study identifies the spoligotyping...